A director at Investor AB bought 7,000 shares at 290.650SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Key takeaways from last week: 1) VEF’s largest holding Creditas announced a milestone partnership with Nubank; 2) Kinnevik invested USD100m in US mental health benefits platform Spring Health; 3) Aker is to sell its 62% stake in Ocean Yield; and 4) Svolder reported its year-end results.
Key takeaways from last week: 1) Latour invests in battery charger supplier CTEK in conjunction with the latter’s planned IPO; 2) Kinnevik will receive at least SEK2bn in extraordinary distributions post Tele2’s exit from the Netherlands; 3) Finnish SPAC Virala traded up 35%+ last week, which could improve the sentiment for Nordic SPACs; and 4) Investor-owned Sarnova acquired a strategic add-on for ~USD290m.
Key takeaways from last week: 1) Investor continues its portfolio pruning, and supported Agnafit Bidco’s SEK69bn equity value offer for Sobi; 2) we hosted VNV Global’s CEO at DNB’s Nordic TMT & Consumer Conference; and 3) we come away encouraged by Investor’s sell-side briefing on Patricia Industries.
Key takeaways: 1) we downgraded Lundbergs to SELL (HOLD) on valuation concerns; 2) Latour remains in fair valuation territory despite its high premium to reported NAV; 3) VEF completed a SEK885m directed share issue; and 4) Bloomberg reported that a consortium is weighing up an acquisition of Investor-owned SOBI.
Key takeaways from last week: 1) the sector premium to NAV contracted by ~5%-points on growing valuation concerns; 2) VEF has had a busy few months, and we continue to believe the story is overlooked; and 3) Bure reported Q2 NAV and is one of only two companies to outperform the SIXRX on NAV growth YTD.
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Key takeaways from last week: 1) we downgraded Kinnevik to HOLD (BUY) as we find most near-term catalysts are reflected in the share price, as the stock is trading at a well-deserved premium to NAV; 2) we still believe Investor offers the best risk/reward profile in the sector; and 3) we see good value in Aker. We do not expect to publish the next weekly navigator until early August.
We still find Investor fundamentally attractive as the ideal portfolio anchor set for a benchmark index outperformance following solid Q2 results where strong cash flows took centre stage. We forecast 8% 12-month forward NAV growth from its attractive portfolio, with potential upside from its self-sustainable cash flow platform, and apply a 5% target discount to NAV. Our model indicates a 12% discount to NAV, versus the sector average premium of 12%, suggesting the most attractive risk/reward pr...
Key takeaways from last week: 1) Kinnevik’s fintech holding Pleo saw a 4x valuation uplift in its recent USD150m funding round; 2) we stayed on the sidelines in Industrivärden, reiterating our HOLD; and 3) VEF shares soared 13% last week, which we attribute to its recent Swedish redomestication.
Key takeaways from last week include: 1) we hosted Investor’s CFO Helena Saxon for an investor call; 2) VEF’s second-largest holding, Konfio, raised USD125m, broadly in line with VEF’s reported NAV valuation; and 3) VNV Global initiated share buybacks to tackle its discount to NAV.
Key takeaways from last week: 1) Kinnevik and VNV Global-owned Babylon Health is expected to go public in H2 2021 through a SPAC merger; 2) we hosted Latour’s CEO for an investor presentation; 3) we still see an arbitrage opportunity in Kinnevik’s redemption shares; and 4) the 180-day lock-up since the Douglas family sold Latour shares in December has expired.
Key takeaways from last week: 1) we reiterated our HOLD on Lundbergs; 2) we see a ‘wall-of-cash’ story developing in Kinnevik’s largest holding Tele2 after its CMD; 3) Latour is expected to be included in the OMXSB Index; and 4) we are set to host management presentations for eight investment companies.
Key takeaways from last week: 1) Kinnevik’s share price soared 10% in the first week of trading without Kinnevik’s redemption shares; 2) we see an arbitrage opportunity in Kinnevik’s redemption shares; 3) Industrivärden bought 4.5m shares in Sandvik for SEK1bn; and 4) Ratos is considering a listing of Aibel.
The general evaluation of INVESTOR AB (SE), a company active in the Speciality Finance industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date May 18, 2021, the closing price was SEK...
Key takeaways from last week: 1) Industrivärden reinvested part of its received dividends in Essity by acquiring 1.4m shares; 2) Kinnevik traded down 10%, which we attribute to a broader rotation out of pandemic ‘winners’; 3) Aker’s Q1 NAV was spot-on our estimate; and 4) Ratos continued its improved earnings momentum in Q1 – its seventh consecutive quarter of strong EBITA growth.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.